Cargando…
Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is associated with obesity, insulin resistance and dyslipidaemia and currently is estimated to affect up to a third of all individuals in developed countries. Current standard of care for patients varies according to disease stage, but includes l...
Autores principales: | Shepherd, Emma L, Karim, Sumera, Newsome, Philip N, Lalor, Patricia F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701969/ https://www.ncbi.nlm.nih.gov/pubmed/33312420 http://dx.doi.org/10.4254/wjh.v12.i11.931 |
Ejemplares similares
-
Changes in human hepatic metabolism in steatosis and cirrhosis
por: Schofield, Zoe, et al.
Publicado: (2017) -
Hemodynamic changes in hepatic sinusoids of hepatic steatosis mice
por: Fan, Jing, et al.
Publicado: (2019) -
Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease
por: Saeed, Waqar Khalid, et al.
Publicado: (2018) -
Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism
por: He, Miao, et al.
Publicado: (2020) -
circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling
por: Guo, Xing-Ya, et al.
Publicado: (2018)